Zaw Min Oo, Ph.D. Email and Phone Number

• Leads forecasting and analytics workstreams for Hematology and Respiratory portfolios. Supports long-term demand planning, including successful facilitation of TA-level workshops, assumptions documentation, and consolidation & presentation of outputs.• Support business development due diligence activities across Therapeutic Areas by leading forecasting and valuation of potential in-licensing/business development opportunities.

● Conducted BD&L analysis to identify high priority target assets, quantified the associated opportunities, and developed tailored BD messaging and roadmap to support business development engagement for a biotechnology company seeking partnership opportunities for its drug delivery technology platform.● Developed launch plan and commercialization roadmap for a specialty biopharmaceutical company launching a new product. Co-lead cross-functional discussions and workshops to define key milestones, activities, and interdependencies relevant to product launch.● Designed and conducted primary market research to understand current market landscape and assess potential market opportunity for a new product for a commercial-stage specialty pharmaceutical company. Developed launch plan and commercialization roadmap to guide product launch.

• Directed market research projects for lead pipeline assets and conducted market opportunity assessments.• Drove forecast assumptions development for market assessments and product valuations in collaboration with senior leadership. Developed and maintained financial models in support of portfolio management and prioritization.• Developed and maintained investor relations materials including corporate presentations in collaboration with senior leadership.

• Led scientific, competitive, and commercial due diligence evaluations of new licensing and collaboration opportunities including therapeutic assets and intellectual properties. Prepare and present to senior leadership summary recommendations related to the opportunities.• Prepared and maintained corporate materials such as press releases, business plans, board materials, and investor presentations to support management team's interaction with external stakeholders.• Managed translational research projects with external partners in generation of IND-enabling data for pre-clinical rare disease programs.

• Supported due diligence efforts in evaluating therapeutic assets and intellectual properties for in-licensing, presented summaries and recommendations to senior management, and developed investment narratives. • Developed competitive landscapes by analyzing advanced pipeline assets and clinical trial competitions surrounding company’s two clinical programs, and presented to development teams and senior management, influencing the clinical strategy and Target Product Profiles.• Managed translational research projects with external partners in generation of IND-enabling data for pre-clinical rare disease programs.• Maintained internal knowledge base in areas of scientific and clinical interests to the company through scientific conference attendance, KOL interactions, and literature reviews.

• Conducted primary research to develop customer insights and refined product-market fit for a startup developing a medical device for COPD treatment, identifying pulmonologists as an important stakeholder and customer segment.• Conducted secondary research to assess unmet need, competitive and payer landscape in COPD; leveraging insights to develop target market size, R&D budget, and cash-flow analysis and forecast.

• Conducted primary and secondary research for a genomic research center to evaluate the current landscape and commercial viability of precision medicine-based drug development in rare and orphan diseases. Generated slide deck highlighting client as a flagship exemplar of precision medicine in practice, and recommended near and long-term strategies to strengthen client’s competitive advantage.• Designed and conducted primary research to understand best practices in researcher outreach, and to identify opportunities for improvement for a non-profit organization dedicated to a rare disease. Recommended and implemented a revised outreach plan, improving client’s physicians and researchers engagement by 25%.

• Developed and demonstrated efficacy of novel anti-leukemia therapeutics in translational models of acute myeloid leukemia (AML).• Investigated the role of a leukemogenic transcription factor on hematopoietic stem cells using transgenic mouse models.